BioSpace News Archive

Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the “Common Share”) for the month of April 2020, which is payable on May 15, 2020 to shareholders of record at the close of business on April 30, 2020. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada). About Extendicare Extendicare i

Pharmaceutical consortium to leverage existing platform to accelerate development of treatments and vaccines for COVID-19

Bold Therapeutics, a clinical-stage biopharmaceutical company, announced that it initiated a research partnership with researchers from the University of Ottawa to explore the potential utility of BOLD-100 as a novel antiviral agent. “We will be using our lentiviral-based infection system, derived from HIV, equip

aptihealth, the nation’s leading innovator in tech-enabled behavioral health engagement, today announced further expansion of its leadership team with the appointment of aptihealth co-founder Joe Kelly, LCSW, as Clinical Operations Director.

Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), a company (i) that has developed medical foods and medical devices in the ocular health marketplace and (ii) that is developing nutraceuticals that the Company believes will provide health benefits to consumers, announced today that Michael Favish, CEO of Guardion Health Sciences,

A program by pharmacy benefit manager Prime Therapeutics LLC, in which a managed care pharmacist reviewed members’ drug therapies including a number of high-cost specialty medications, saved a net $2.4 million in health care costs in one year.

GE Healthcare today introduced a new software solution to support clinicians and health systems in the treatment of COVID-19 patients. The company is bringing its Mural Virtual Care Solution, which i

Aeterna Zentaris Inc. , today announced that Dr. Klaus Paulini , Chief Executive Officer of Aeterna Zentaris will present at the April 2020 Virtual Investor Summit on Thursday, April 23, 2020 at 10:00 AM ET. A live audio webcast of the presentation will be ava

FUJIFILM Corporation has announced that it has expanded its manufacturing capacity at FUJIFILM Toyama Chemical Co., Ltd. to significantly increase production of its influenza antiviral drug “Avigan® Tablet” for treating patients with COVID-19..

TCR2 Therapeutics Inc., a clinical-stage immunotherapy company developing the next generation of novel T cell therapies for patients suffering from cancer, announced the appointment of Axel Hoos, M.D., Ph.D., to its Board of Directors.